A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?

Arch Iran Med. 2008 May;11(3):306-13.
No abstract available

MeSH terms

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Aspirin / therapeutic use
  • Cardiovascular Diseases / prevention & control*
  • Drug Combinations
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Myocardial Infarction / prevention & control*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Primary Prevention

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Drug Combinations
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Platelet Aggregation Inhibitors
  • Aspirin